73.3 F
Saturday, July 31, 2021

New COVID-19 antiviral to be tested in Mérida

Recent headlines

Will Yucatán’s love for cheese beat out its fear of COVID-19?

Event organizers have been quick to point out that they will be following all sanitary protocols, to protect vendors and patrons from COVID-19. 

Looking to buy ceramics? Look no further than Ticul

When entering the town on the road from the nearby town of Muna, you will notice a string of several shops ceiling ceramic crafts, plates, ornaments, and pots. 

Building in Mérida: Permits and contracts for the historic center

In Mérida, construction permits are different depending on the area in which you’re building. As the Centro Histórico is one of the most popular neighborhoods for newcomers, there are some technical — and legal considerations to keep in mind.
Carlos Rosado van der Gracht
Born in Mérida, Carlos Rosado van der Gracht is a Mexican/Canadian blogger, photographer and adventure expedition leader. He holds degrees in multimedia, philosophy and translation from universities in Mexico, Canada and Norway. Sign up for the Yucatán Roundup, a free newsletter, which delivers the week's top headlines every Monday.
Researchers hope that the experimental drug, called molnupiravir, will prove effective in the treatment of COVID-19. Photo: Courtesy

The American pharmaceutical company MSD is recruiting volunteers in Mérida for trials of a new orally administered antiviral drug targeting COVID-19. 

The experimental drug seeks to stop the COVID-19 virus from replicating inside the human body, thus leading to quicker recovery. 

“We are really excited to be entering this decisive phase in our research. This drug has the potential to help COVID-19 patients, especially those in the initial stages of the disease,” says Claudio González, director of SMD Mexico.

Drug trials are to be carried out on volunteers of both sexes over the age of 18 who have contracted COVID-19 in the last year and experienced at least one symptom. 

Earlier: The skyrocketing value of colonial homes in downtown Mérida

The results of the drug trial are expected to be published for peer review in October.

This is not the first time that drug trials targeting COVID-19 have been held in Mérida. Last year, CanSino Biologics began testing its coronavirus vaccine in Yucatán in cooperation with the Mérida-based research institute Köhler & Milstein.

Accumulated coronavirus cases in Yucatán are close to 48,000; deaths overall have totaled 4,556 since April 2020.

Yesterday, Yucatán reported 19 COVID-19 deaths, the highest single-day number since the beginning of the virus’s third wave which began earlier this summer. 

More news

COVID maps: Yucatán making progress but restrictions remain

Yucatán is upgraded from orange to yellow under a national stoplight system that assesses coronavirus risk. But the state's own map...

Goal: 1,000 toothbrushes, toothpaste for kids in 4 small villages

Pedro Tec and the Yucatán nonprofit foundation Los Mayas Eternos AC are working on a new oral health campaign for children from four small towns.

MACAY will close for good without funding, says leader

The MACAY, the only contemporary art museum on the Yucatán Peninsula, could close for good this week. Photo: File

Entertaining at home: Simple and festive Yucatán-inspired tablescapes

Here are some nearby shops to make your tabletop pop.